Florida Advisory Council on Radiation Protection endorses ASTRO's Target Safely patient protection plan

Through a unanimous decision, the Florida Advisory Council on Radiation Protection has endorsed Target Safely, the American Society for Radiation Oncology's (ASTRO) patient protection plan.

ASTRO's Board of Directors developed Target Safely after a systemic review of the Society's patient safety and quality assurance projects, which began as part of the Board's winter meeting January 28-31, 2010. The goal of the plan is to improve safety and quality and reduce the chances of medical errors.

"The Florida Bureau of Radiation Control and the Advisory Council on Radiation Protection are pleased to endorse ASTRO's Target Safely plan," William Passetti, chief of the Florida Department of Heath Bureau of Radiation Control, said. "We are always looking for partners to work with to help reduce any unnecessary radiation exposure to people in Florida and feel this plan is an important piece toward that end."

Many of the 11 million cancer survivors alive today have benefited from radiation therapy. While all forms of cancer treatment have some inherent risks, when properly used radiation therapy has been, and will continue to be, an essential part of cancer therapy. Recent technological advances have made it possible to precisely define the targets and eliminate tumors while sparing healthy, normal tissue and minimizing side effects. The radiation treatments given today, whether alone or in combination with chemotherapy and surgery, are safer, more accurate and more effective than treatments that were given just 10 or 20 years ago. More and more patients are winning their battles with cancer and going on to lead healthy and productive lives.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows AI can predict prognosis in triple-negative breast cancer